Valuation: Celltrion Pharm, Inc.

Market Cap 4,674B 6,201,883B 4,179B 3,866B 3,501B 6,552B 444,656B 6,660B 46,528B 18,404B 232,571B 17,541B 17,166B 736,381B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 6,418,544B 4,325B 4,002B 3,623B 6,781B 460,190B 6,892B 48,153B 19,047B 240,696B 18,154B 17,766B 762,106B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.16%
Yield 2019 *
-
Yield 2020 -
1 day-2.93%
1 week-8.75%
Current month-4.20%
1 month-6.53%
3 months-9.65%
6 months-37.39%
Current year-37.07%
1 week 36,450
Extreme 36450
40,850
1 month 35,600
Extreme 35600
40,850
Current year 35,600
Extreme 35600
78,300
1 year 35,600
Extreme 35600
78,300
3 years 35,600
Extreme 35600
124,463.12
5 years 35,600
Extreme 35600
124,463.12
10 years 13,660.97
Extreme 13660.974887
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 26/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 55 -
Director TitleAgeSince
Chairman 69 28/03/2025
Chairman 42 26/03/2024
Director/Board Member 61 26/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
7/5/25 Others 24 0.0001%
7/5/25 Others 127 0.0003%
7/5/25 Exercice 4,500 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-2.93%-8.75%-34.22%-36.16% 1.25B
+0.45%+3.13%+54.96%+125.16% 1,135B
+0.94%+4.93%+39.86%+78.72% 635B
+0.39%+1.44%+25.77%+97.48% 505B
+1.43%+4.31%+46.20%+67.12% 378B
-3.21%-2.10%+60.72%+33.22% 358B
-0.41%+2.64%+22.48%+49.82% 295B
+0.23%+3.66%+2.57%+23.69% 266B
+1.22%+4.63%+52.40%+64.85% 237B
+1.70%+3.67%+31.21%+102.15% 193B
Average -0.05%+0.70%+30.20%+60.61% 400.49B
Weighted average by Cap. +0.42%+1.63%+41.38%+83.57%

Financials

2019 2020
Net sales 174B 230,248B 155B 144B 130B 243B 16,508B 247B 1,727B 683B 8,634B 651B 637B 27,339B 234B 309,941B 209B 193B 175B 327B 22,222B 333B 2,325B 920B 11,623B 877B 858B 36,801B
Net income 8.6B 11,415B 7.69B 7.12B 6.44B 12.06B 818B 12.26B 85.64B 33.87B 428B 32.29B 31.6B 1,355B 20.94B 27,787B 18.72B 17.32B 15.68B 29.36B 1,992B 29.84B 208B 82.46B 1,042B 78.59B 76.91B 3,299B
Net Debt 149B 197,128B 133B 123B 111B 208B 14,133B 212B 1,479B 585B 7,392B 558B 546B 23,406B 163B 216,661B 146B 135B 122B 229B 15,534B 233B 1,625B 643B 8,125B 613B 600B 25,725B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
26/10/26 KRW 36,500.00 -2.93% 41,161
23/10/26 KRW 37,600.00 -2.59% 44,351
22/10/26 KRW 38,600.00 -1.91% 59,209
21/10/26 KRW 39,350.00 -0.13% 49,244
20/10/26 KRW 39,400.00 -1.50% 61,227
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock